Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers-Reference-Cited by-同舟云学术

Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers

Published:2015-09-30 Issue:11 Volume:12 Page:4085-4098
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Yi Xiaoli¹,Lian Xianghong¹,Dong Jianxia¹,Wan Zhuoya¹,Xia Chunyu¹,Song Xu¹,Fu Yao¹,Gong Tao¹,Zhang Zhirong¹

Affiliation:

1. Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, Sichuan University, Sichuan, People’s Republic of China

Funder

Ministry of Science and Technology of the People's Republic of China

Sichuan University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00536

Reference72 articles.

1. Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer

2. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

3. Engineering Particles for Therapeutic Delivery: Prospects and Challenges

4. Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment

5. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis;Biomedicine & Pharmacotherapy;2024-10

2. Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy;Medicine in Drug Discovery;2024-06

3. Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities;Journal of Drug Delivery Science and Technology;2024-05

4. Preparation and <i>in Vitro</i> Characterization of Fatty-Acid Modified Pirarubicin Nanosuspensions Stabilized by Albumin;Chemical and Pharmaceutical Bulletin;2024-01-01

5. Nanocarrier-based Systems for Co-delivery of Drugs in the Management of Skin Cancer: A Review;Current Nanomedicine;2023-11